Reports Outline Managed Care and Specialty Pharmacy Findings from High Point University (Prevalence, Characteristics, and Health-related Quality of Life of Continuous Glucose Monitoring Use According To the Behavioral Risk Factor Surveillance …): Drugs and Therapies – Managed Care and Specialty Pharmacy

2023 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Current study results on Drugs and Therapies - Managed Care and Specialty Pharmacy have been published. According to news reporting out of High Point, North Carolina, by NewsRx editors, research stated, “Continuous glucose moni-toring (CGM) can improve behavioral and clinical outcomes. The use of CGM in real-world practice appears to be increasing.”

Our news journalists obtained a quote from the research from High Point University, “However, actual prevalence and character-istics of using CGM in real-world practice are unknown. To investigate the prevalence of CGM use by American adults with diabetes mellitus and differences in demographics and health-related quality of life (HRQOL) between users of CGM and self-monitoring of blood glucose (SMBG). This serial cross-sectional study using 2014-2020 Behavioral Risk Factor Surveillance System data included nonpreg-nant adults with self-reported diabetes using CGM or 4-15 times daily SMBG. Outcomes were prevalence of CGM use, demographics, and the 4-item Centers for Disease Control and Prevention HRQOL (CDC HRQOL-4). Unadjusted analysis was performed using uni-variable regression, and adjusted analysis was performed using nearest neighbor matching to compare CDC HRQOL-4 between SMBG and CGM groups in SAS Studio version 5.2.Among 12,053 included respon-dents, 231 (1.9%) reported using CGM, and prevalence increased from 0.4% in 2014 to 4.1% in 2020. Compared with SMBG users, CGM users were more likely to be younger (50.3 years vs 56.1 years; P< 0.001), employed (59.6% vs 30.6%; P = 0.001), earn at least $75,000/year (48.5% vs 22.0%, P< 0.001), have insurance coverage (99.7% vs 95.4%; P = 0.005), and report fewer comorbidities (history of myocardial infarction, stroke, arthritis, depressive disorder, and kidney disease; all P< 0.05). After nearest neighbor matching, diabetes management-related characteristics were shown to have statisti-cally significant differences between CGM and SMBG users including: age at diabetes diagnosis (30.6 vs 35.6 years; P = 0.005), not seeing a doctor because of cost concern (2.6% vs 7.8%; P = 0.011), checking hemoglobin A1c biannually (91.3% vs 86.6%; P = 0.047), performing daily foot self-examination (58.9% vs 69.6%; P = 0.028), receiving foot examina-tion by a health care professional annually (87.9% vs 93.5%; P = 0.048), and receiving a shingles vaccine in the past (16.5% vs 10.1%; P = 0.024). CDC HRQOL-4 were shown to be similar between the 2 groups across the 4 domains (general health, physical, mental, and combined physical and mental health). An increased trend in CGM use was observed from 2014 to 2020.”

According to the news editors, the research concluded: “Economic factors were associated with CGM use over SMBG, and CGM use did not show a difference in HRQOL measured across the 4 domains.”

This research has been peer-reviewed.

For more information on this research see: Prevalence, Characteristics, and Health-related Quality of Life of Continuous Glucose Monitoring Use According To the Behavioral Risk Factor Surveillance System 2014-2020. Journal of Managed Care & Specialty Pharmacy, 2023;29(5):541-549. Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

Our news journalists report that additional information may be obtained by contacting Sun Lee, High Point University, Fred Wilson Sch Pharm, Dept. of Clinical Sciences, High Point, NC 27268, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)